EyePoint (EYPT) Gross Profit (2018 - 2026)

EyePoint (EYPT) reported Gross Profit of $168000.0 for Q1 2026, down 99.29% on a YoY basis from $23.6 million in Q1 2025, and down 31.43% sequentially from $245000.0 in Q4 2025.

EyePoint (EYPT) Gross Profit (2018 - 2026) Analysis & Trends

EyePoint (EYPT) has 9 years of Gross Profit data on file, last reported at $168000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Gross Profit fell 99.29% year-over-year to $168000.0; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (down 88.86% YoY), and the FY2025 full-year result was $29.3 million, down 25.92% from the prior year.
  • Gross Profit slipped to $168000.0 in Q1 2026, from $245000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $23.6 million in Q1 2025 to a low of $168000.0 in Q1 2026.
  • A 5-year average of $8.4 million and a median of $8.1 million in 2024 frame the typical range for Gross Profit.
  • Across the five-year window, Gross Profit jumped 116.46% in 2025 and tumbled 99.29% in 2026, its largest moves.
  • Tracing EYPT's Gross Profit over 5 years: stood at $7.1 million in 2022, then surged by 82.93% to $13.0 million in 2023, then fell by 17.33% to $10.8 million in 2024, then plunged by 97.73% to $245000.0 in 2025, then sank by 31.43% to $168000.0 in 2026.
  • Business Quant data shows EYPT's Gross Profit at $168000.0 in Q1 2026, $245000.0 in Q4 2025, and $245000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 168,000.00
Mar 31, 2026 168,000.00
Dec 31, 2025 245,000.00
Dec 31, 2025 245,000.00
Sep 30, 2025 245,000.00
Sep 30, 2025 245,000.00
Jun 30, 2025 5.17 Mn
Jun 30, 2025 5.17 Mn
Mar 31, 2025 23.65 Mn
Mar 31, 2025 23.65 Mn
Dec 31, 2024 10.77 Mn
Dec 31, 2024 10.77 Mn
Sep 30, 2024 9.79 Mn
Sep 30, 2024 9.79 Mn
Jun 30, 2024 8.08 Mn
Jun 30, 2024 8.08 Mn
Mar 31, 2024 10.93 Mn
Mar 31, 2024 10.93 Mn
Dec 31, 2023 13.03 Mn
Dec 31, 2023 13.03 Mn